A Phase II Trial of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults
Phase of Trial: Phase II
Latest Information Update: 14 May 2019
Price : $35 *
At a glance
- Drugs Ascorbic acid (Primary) ; Gemcitabine (Primary)
- Indications Liposarcoma; Osteosarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 27 Feb 2019 Status changed from recruiting to suspended due to interim analysis.
- 11 Jul 2018 Status changed from not yet recruiting to recruiting.
- 05 Jul 2018 Planned initiation date changed from 1 Jun 2018 to 1 Aug 2018.